We are live on ! Find out more
BBI

Baxter Bros Inc Portfolio holdings

AUM $810M
1-Year Est. Return 16.24%
This Fund
S&P 500
This Quarter Est. Return
+8.47%
1 Year Est. Return
+16.24%
3 Year Est. Return
+68.81%
5 Year Est. Return
+86.22%
10 Year Est. Return
+312.36%
AUM
$417M
AUM Growth
+$44.7M
Cap. Flow
+$13.1M
Cap. Flow %
3.14%
Top 10 Hldgs %
42.4%
Holding
117
New
6
Increased
50
Reduced
41
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 21.95%
2 Technology 20.47%
3 Industrials 15.62%
4 Communication Services 11.94%
5 Healthcare 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBD icon
76
Warner Bros
WBD
$67.4B
$614K 0.15%
19,200
MRK icon
77
Merck
MRK
$315B
$610K 0.15%
9,011
-523
-5% -$33.3K
EXPD icon
78
Expeditors International
EXPD
$23.9B
$544K 0.13%
7,400
AMT icon
79
American Tower
AMT
$79.2B
$523K 0.13%
3,597
+17
+0.5% +$2.49K
BUD
80
DELISTED
ANHEUSER BUSCH COS INC
BUD
$499K 0.12%
5,698
-290
-5% -$25.4K
LSXMA
81
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$495K 0.12%
15,779
-2,768
-15% -$92.9K
NFLX icon
82
Netflix
NFLX
$290B
$483K 0.12%
12,910
+760
+6% +$27.6K
PNR icon
83
Pentair
PNR
$10.1B
$468K 0.11%
10,800
-400
-4% -$17.4K
RY icon
84
Royal Bank of Canada
RY
$299B
$446K 0.11%
5,559
BHC icon
85
Bausch Health
BHC
$1.8B
$408K 0.1%
+15,900
New +$364K
ABT icon
86
Abbott
ABT
$175B
$367K 0.09%
5,003
+42
+0.8% +$2.76K
DE icon
87
Deere & Co
DE
$161B
$361K 0.09%
2,400
DVN icon
88
Devon Energy
DVN
$50.6B
$352K 0.08%
8,810
-835
-9% -$35.5K
BIIB icon
89
Biogen
BIIB
$30.4B
$344K 0.08%
974
-28
-3% -$9.64K
GIS icon
90
General Mills
GIS
$20.3B
$302K 0.07%
7,042
TVRD
91
Tvardi Therapeutics
TVRD
$30M
$299K 0.07%
+347
New +$251K
IMGN
92
DELISTED
Immunogen Inc
IMGN
$292K 0.07%
30,800
CSCO icon
93
Cisco
CSCO
$441B
$289K 0.07%
5,933
+639
+12% +$28.7K
LBTYA icon
94
Liberty Global Class A
LBTYA
$3.52B
$289K 0.07%
10,000
GILD icon
95
Gilead Sciences
GILD
$167B
$263K 0.06%
3,410
-50
-1% -$3.78K
ORCL icon
96
Oracle
ORCL
$364B
$257K 0.06%
4,987
+46
+0.9% +$2.23K
CTAS icon
97
Cintas
CTAS
$81.8B
$246K 0.06%
4,976
HUM icon
98
Humana
HUM
$48B
$211K 0.05%
+623
New +$202K
ABBV icon
99
AbbVie
ABBV
$450B
$208K 0.05%
2,199
-850
-28% -$80.6K
BAX icon
100
Baxter International
BAX
$11.7B
$201K 0.05%
+2,606
New +$193K

Similar funds

Baxter Bros Inc's Q3 2018 Portfolio in Review

As of Q3 2018, Baxter Bros Inc held 117 positions worth $417M, up 12% from $372M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Baxter Bros Inc deployed $13.1M of net new capital in Q3 2018, opening 6 new positions and adding to 50 existing holdings. Its largest new stake was Bausch Health: 15,900 shares worth $408K.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was GE Aerospace, an estimated $835K trimmed.

  • Baxter Bros Inc's largest Q3 2018 buy was Bausch Health: 15,900 shares worth $408K.
  • Baxter Bros Inc added most to Texas Instruments in Q3 2018, an estimated $3.31M increase.
  • Baxter Bros Inc's biggest Q3 2018 reduction was GE Aerospace, cutting an estimated $835K.
  • Baxter Bros Inc fully exited VALEANT PHARMACEUTICALS INTL in Q3 2018, selling an estimated $370K.
  • Baxter Bros Inc's ten largest holdings make up 42% of its $417M portfolio in Q3 2018.
  • Baxter Bros Inc opened 6 new positions and closed 6 in Q3 2018.
  • Baxter Bros Inc's portfolio value rose 12% quarter-over-quarter to $417M.

Based on Baxter Bros Inc's 13F filing for Q3 2018, filed 11 Oct 2018.